Full Text View
Tabular View
No Study Results Posted
Related Studies
Randomized Clinical Trial of Triptolide Woldifii for Autosomal Dominant Polycystic Kidney Disease
This study is currently recruiting participants.
Verified March 2013 by Nanjing University School of Medicine
Study NCT00801268   Information provided by Nanjing University School of Medicine

First Received on November 25, 2008.   Last Updated on March 29, 2013   History of Changes
Related Studies can be found by searching for the Conditions, Interventions, and Sponsors found in this study:
Conditions listed in this trial
Polycystic Kidney
Additional conditions recognized in this trial
Kidney Diseases
Polycystic Kidney Diseases
Polycystic Kidney, Autosomal Dominant
More general conditions related to this trial
Kidney Diseases, Cystic
Urologic Diseases
Interventions listed in this trial
tripterygium wilfordii
Emodin
Additional drug interventions recognized in this trial
Triptolide
More general drug interventions related to this trial
Alkylating Agents
Antineoplastic Agents
Antineoplastic Agents, Alkylating
Antispermatogenic Agents
Cathartics
Contraceptive Agents
Contraceptive Agents, Male
Enzyme Inhibitors
Gastrointestinal Agents
Immunologic Factors
Immunosuppressive Agents
Molecular Mechanisms of Pharmacological Action
Pharmacologic Actions
Physiological Effects of Drugs
Protein Kinase Inhibitors
Reproductive Control Agents
Therapeutic Uses
Sponsors listed in this trial
Zhi-Hong Liu, M.D.


Contact Help Desk
Lister Hill National Center for Biomedical Communications,  U.S. National Library of Medicine,
U.S. National Institutes of Health,  U.S. Department of Health & Human Services,
USA.gov,  Copyright,  Privacy,  Accessibility,  Freedom of Information Act

U.S. National Institutes of Health U.S. National Library of Medicine U.S. Department of Health & Human Services